Stryker (SYK) Research & Development (2009 - 2026)

Stryker (SYK) has 18 years of Research & Development data on file, last reported at $413.0 million in Q1 2026.

• On a quarterly basis, Research & Development rose 1.98% year-over-year to $413.0 million in Q1 2026; TTM through Mar 2026 was $1.6 billion, a 8.52% increase from a year earlier, with the FY2025 full-year figure at $1.6 billion, up 10.71% from the prior year.
• Research & Development for Q1 2026 stood at $413.0 million, up from $401.0 million in the prior quarter.
• Over the last five years, Research & Development for SYK reached as high as $413.0 million in Q1 2022 and fell as low as $326.0 million in Q4 2022.
• Historically, Research & Development has averaged $373.2 million across 5 years, with a median of $364.0 million in 2022.
• Across the five-year window, Research & Development soared 43.4% in 2022 and declined 17.92% in 2023, its largest moves.
• Year by year, Research & Development stood at $326.0 million in 2022, then climbed by 7.36% to $350.0 million in 2023, then advanced by 2.29% to $358.0 million in 2024, then grew by 12.01% to $401.0 million in 2025, then gained by 2.99% to $413.0 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $413.0 million in Q1 2026, $401.0 million in Q4 2025, and $410.0 million in Q3 2025.